| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $2,703,428 ) |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R34MH132473 | Enhancing communication on relationship preservation, safer conception and PrEP to promote HIV testing | 000 | 3 | NIH | 12/19/2024 | $177,109 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 8 | HRSA | 12/9/2024 | $788,051 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23HL153895 | The Impact of Public Reporting on Procedural Outcomes Following Congenital Heart Surgery | 000 | 4 | NIH | 12/9/2024 | $166,869 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 8 | HRSA | 12/9/2024 | $363,541 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01DK139636 | SIGIRR in the Neonatal Intestine | 000 | 1 | NIH | 12/31/2024 | $630,847 |
| | 2025 | 2025 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD110447 | Systematic Identification and Phenotypic Characterization of causal genetic variants in Rare Disease-Associated Birth Defects | 000 | 3 | NIH | 11/22/2024 | $577,011 |
| | 2025 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD111570 | Unraveling the Genomic Causes for Unsolved Leukodystrophy Patients by HiFi-GS | 000 | 1 | NIH | 11/25/2024 | $0 |
| | 2025 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | H9E53187 | Transition for Youth with Autism and/or Epilepsy Demonstration Projects | 02 | 1 | HRSA | 12/16/2024 | $0 |
| | 2025 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R13CA281369 | The 10th International MDM2 Workshop | 000 | 1 | NIH | 1/7/2025 | $0 |
| | 2025 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01DK066143 | Chronic Kidney Disease in Children (CKiD V) | 001 | 21 | NIH | 11/26/2024 | $125,000 |
| | 2025 | 2023 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01DK066143 | Chronic Kidney Disease in Children (CKiD V) | 001 | 21 | NIH | 11/26/2024 | $2,342 |
| | 2025 | 2022 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | GE146331 | Community Project Funding/Congressionally Directed Spending - Non-Construction | 07 | 1 | HRSA | 12/9/2024 | $0 |
| | 2025 | 2022 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01DK066143 | Chronic Kidney Disease in Children (CKiD V) | 000 | 20 | NIH | 11/26/2024 | -$125,000 |
| | 2025 | 2022 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01DK066143 | Chronic Kidney Disease in Children (CKiD V) | 000 | 20 | NIH | 11/26/2024 | -$2,342 |
| | 2025 | 2022 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01DK117296 | Single Immunoglobulin Interleukin-1 Related Receptor and necrotizing enterocolitis in premature infants | 000 | 5 | NIH | 12/12/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $21,702,948 ) (Continued on the next page) |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23DA055736 | Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital | 000 | 3 | NIH | 4/17/2024 | $189,540 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 06 | 7 | HRSA | 9/24/2024 | $145,835 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 7 | HRSA | 12/6/2023 | $211,894 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 00 | 7 | HRSA | 12/6/2023 | $461,005 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 7 | HRSA | 1/29/2024 | $419,182 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 01 | 7 | HRSA | 1/29/2024 | $911,987 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 03 | 7 | HRSA | 6/3/2024 | $448,572 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 03 | 7 | HRSA | 6/3/2024 | $975,930 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T32HD069038 | Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology | 001 | 14 | NIH | 6/17/2024 | $298,713 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01DK066143 | Chronic Kidney Disease in Children (CKiD V) | 000 | 22 | NIH | 7/9/2024 | $175,000 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01DK066143 | Chronic Kidney Disease in Children (CKiD V) | 000 | 22 | NIH | 7/9/2024 | $949,419 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 4 | CDC | 9/17/2024 | $0 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 4 | CDC | 9/17/2024 | $0 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 4 | CDC | 9/17/2024 | $0 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 01 | 4 | CDC | 9/17/2024 | $0 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 00 | 4 | CDC | 7/5/2024 | $78,000 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 00 | 4 | CDC | 7/5/2024 | $0 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 00 | 4 | CDC | 7/5/2024 | $1,142,857 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 00 | 4 | CDC | 7/5/2024 | $3,428 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | U01IP001154 | IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | 00 | 4 | CDC | 7/5/2024 | $10,000 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01HD100545 | A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma | 000 | 5 | NIH | 6/7/2024 | $283,465 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K08DK125735 | Gene-environment interactions in necrotizing enterocolitis: impact of SIGIRR mutation and gut microbiota on intestinal TLR hyperactivity | 000 | 5 | NIH | 7/9/2024 | $162,396 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | K23HD098299 | Promoting Healthy Relationships among At-Risk Adolescents: A Feasibility Trial in the Emergency Department | 000 | 5 | NIH | 2/29/2024 | $157,950 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01AI147778 | Natural killer cell regulation of the germinal center HIV neutralizing antibody response | 001 | 5 | NIH | 5/15/2024 | $65,366 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01AI147778 | Natural killer cell regulation of the germinal center HIV neutralizing antibody response | 000 | 5 | NIH | 11/17/2023 | $588,304 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R25HG009651 | An Immersive Experience in Medical Genomics | 000 | 7 | NIH | 7/2/2024 | $78,271 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 04 | 7 | HRSA | 9/5/2024 | $989,865 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 04 | 7 | HRSA | 9/5/2024 | $2,111,937 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 05 | 7 | HRSA | 9/17/2024 | $76,926 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 02 | 7 | HRSA | 3/7/2024 | $92,128 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | T2331564 | Children's Hospitals Graduate Medical Education Payment Program | 02 | 7 | HRSA | 3/7/2024 | $200,437 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01MD015409 | Understanding Mechanisms Underlying Chronic Stress-Induced Asthma in Children by Population and Single-Cell Epigenomics Approaches | 000 | 5 | NIH | 5/3/2024 | $235,663 |
| | 2024 | 2024 | CHILDRENS MERCY HOSPITAL | 2401 GILLHAM RD | KANSAS CITY | MO | 64108-4619 | JACKSON | USA | R01MD015409 | Understanding Mechanisms Underlying Chronic Stress-Induced Asthma in Children by Population and Single-Cell Epigenomics Approaches | 000 | 5 | NIH | 5/3/2024 | $381,801 |
|
